塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/13 | 4,685 | 4,915 | 4,521 | 4,770 | -344 | -6.7% | 2,730,800 |
2020/03/12 | 5,221 | 5,252 | 5,075 | 5,114 | -186 | -3.5% | 1,672,600 |
2020/03/11 | 5,363 | 5,380 | 5,283 | 5,300 | -121 | -2.2% | 1,318,200 |
2020/03/10 | 5,476 | 5,491 | 5,290 | 5,421 | -12 | -0.2% | 1,618,000 |
2020/03/09 | 5,475 | 5,512 | 5,324 | 5,433 | -149 | -2.7% | 1,917,400 |
2020/03/06 | 5,643 | 5,671 | 5,539 | 5,582 | -178 | -3.1% | 1,417,400 |
2020/03/05 | 5,748 | 5,801 | 5,712 | 5,760 | +40 | +0.7% | 1,232,100 |
2020/03/04 | 5,623 | 5,763 | 5,590 | 5,720 | +37 | +0.7% | 1,099,800 |
2020/03/03 | 5,832 | 5,838 | 5,670 | 5,683 | -115 | -2% | 1,562,400 |
2020/03/02 | 5,646 | 5,813 | 5,580 | 5,798 | -47 | -0.8% | 2,546,800 |
2020/02/28 | 5,985 | 5,996 | 5,793 | 5,845 | -240 | -3.9% | 2,038,800 |
2020/02/27 | 6,053 | 6,143 | 6,046 | 6,085 | -29 | -0.5% | 1,368,700 |
2020/02/26 | 6,210 | 6,224 | 6,065 | 6,114 | -123 | -2% | 1,723,300 |
2020/02/25 | 6,187 | 6,292 | 6,172 | 6,237 | -223 | -3.5% | 1,538,400 |
2020/02/21 | 6,505 | 6,578 | 6,434 | 6,460 | +1 | ±0% | 1,237,700 |
2020/02/20 | 6,518 | 6,522 | 6,427 | 6,459 | -92 | -1.4% | 1,397,800 |
2020/02/19 | 6,514 | 6,604 | 6,492 | 6,551 | +47 | +0.7% | 1,589,900 |
2020/02/18 | 6,404 | 6,519 | 6,378 | 6,504 | +133 | +2.1% | 1,295,300 |
2020/02/17 | 6,391 | 6,408 | 6,333 | 6,371 | -93 | -1.4% | 802,400 |
2020/02/14 | 6,431 | 6,474 | 6,390 | 6,464 | +4 | +0.1% | 1,303,900 |
2020/02/13 | 6,486 | 6,499 | 6,411 | 6,460 | -50 | -0.8% | 1,313,100 |
2020/02/12 | 6,672 | 6,672 | 6,456 | 6,510 | -187 | -2.8% | 1,321,500 |
2020/02/10 | 6,716 | 6,733 | 6,636 | 6,697 | -76 | -1.1% | 1,038,100 |
2020/02/07 | 6,691 | 6,796 | 6,650 | 6,773 | +171 | +2.6% | 1,424,900 |
2020/02/06 | 6,592 | 6,647 | 6,535 | 6,602 | +137 | +2.1% | 1,365,400 |
2020/02/05 | 6,401 | 6,490 | 6,368 | 6,465 | +85 | +1.3% | 1,219,400 |
2020/02/04 | 6,397 | 6,438 | 6,261 | 6,380 | -134 | -2.1% | 2,293,100 |
2020/02/03 | 6,572 | 6,775 | 6,473 | 6,514 | -51 | -0.8% | 3,326,200 |
2020/01/31 | 6,550 | 6,655 | 6,530 | 6,565 | -13 | -0.2% | 1,716,100 |
2020/01/30 | 6,660 | 6,699 | 6,540 | 6,578 | -169 | -2.5% | 1,307,400 |
2020/01/29 | 6,714 | 6,747 | 6,673 | 6,747 | +24 | +0.4% | 1,109,400 |
2020/01/28 | 6,690 | 6,744 | 6,627 | 6,723 | +32 | +0.5% | 1,339,900 |
2020/01/27 | 6,580 | 6,701 | 6,561 | 6,691 | -15 | -0.2% | 986,400 |
2020/01/24 | 6,635 | 6,737 | 6,616 | 6,706 | ±0 | ±0% | 1,320,900 |
2020/01/23 | 6,757 | 6,806 | 6,657 | 6,706 | -151 | -2.2% | 1,854,600 |
2020/01/22 | 6,943 | 7,026 | 6,855 | 6,857 | -222 | -3.1% | 1,954,200 |
2020/01/21 | 7,043 | 7,095 | 7,034 | 7,079 | +20 | +0.3% | 727,900 |
2020/01/20 | 7,052 | 7,081 | 7,020 | 7,059 | -66 | -0.9% | 686,600 |
2020/01/17 | 7,056 | 7,133 | 7,048 | 7,125 | +104 | +1.5% | 1,158,300 |
2020/01/16 | 6,950 | 7,032 | 6,947 | 7,021 | +133 | +1.9% | 1,128,600 |
2020/01/15 | 6,969 | 6,982 | 6,877 | 6,888 | -40 | -0.6% | 630,300 |
2020/01/14 | 6,956 | 6,989 | 6,860 | 6,928 | -1 | ±0% | 941,100 |
2020/01/10 | 6,880 | 6,932 | 6,856 | 6,929 | +118 | +1.7% | 1,314,300 |
2020/01/09 | 6,821 | 6,832 | 6,718 | 6,811 | +146 | +2.2% | 1,057,000 |
2020/01/08 | 6,650 | 6,705 | 6,601 | 6,665 | -35 | -0.5% | 1,081,500 |
2020/01/07 | 6,626 | 6,715 | 6,611 | 6,700 | +95 | +1.4% | 1,282,800 |
2020/01/06 | 6,632 | 6,682 | 6,574 | 6,605 | -162 | -2.4% | 1,553,900 |
2019/12/30 | 6,790 | 6,835 | 6,749 | 6,767 | -20 | -0.3% | 598,500 |
2019/12/27 | 6,716 | 6,803 | 6,716 | 6,787 | +22 | +0.3% | 627,800 |
2019/12/26 | 6,829 | 6,834 | 6,749 | 6,765 | -68 | -1% | 685,800 |
1151~
1200
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム